ArticleJournal of Alzheimer's disease : JAD2022

Targeting the Beta-2-Adrenergic Receptor and the Risk of Developing Alzheimer's Disease: A Retrospective Inception Cohort Study.

Danique R Hutten et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.